StockData
Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc. (ACHV) bonds

ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$6.72+0.34 (+5.33%)

Close on Nov 6, 2026Market cap $691.50MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Achieve Life Sciences reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Achieve Life Sciences's 10-Q for the period ended Dec 31, 2025

Achieve Life Sciences's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeExpires
Contingent Convertible Debt Agreement$5.00MJun 1, 2028
Convertible Debt Agreement$5.00M–

See a number that looks wrong?